Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,475,820
-$35,408 QoQ
Shares Held
21,864
-46.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 211 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. ANAB ranks #74 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in ANAB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,475,820 | 21,864 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,511,228 | 27,249 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,711,828 | 35,310 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $921,201 | 30,085 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $595,603 | 26,829 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $579,634 | 31,180 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $938,494 | 70,883 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,296,381 | 38,698 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,244,757 | 49,671 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,042,424 | 90,694 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $1,119,551 | 62,336 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,884,501 | 92,650 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,682,791 | 77,334 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,178,411 | 70,294 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,981,110 | 77,660 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $792,246 | 39,027 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,152,683 | 46,592 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,506,831 | 43,362 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $818,129 | 30,167 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,243,682 | 47,963 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,956,809 | 90,803 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $249,399 | 11,600 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $434,164 | 29,435 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $378,170 | 16,928 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||